Tina Vilsbøll(MD, DMSc) is a Clinical Professor and Head of Clinic at Steno Diabetes Center, Copenhagen, Denmark.

She has been involved in diabetes research since 1997 and in 2004 she established the Center for Diabetes Research at Gentofte Hospital, University of Copenhagen, Denmark, now part of Steno Diabetes Centre Copenhagen. Her research is focused on the pathophysiology of obesity, prediabetes, type 2 diabetes (with a specific focus on insulin, glucagon and incretin hormones), regulation of appetite and food intake, and the utilisation of incretins as therapeutics. Integration of the gut in the understanding of human glucose metabolism has become a major focus in her lab over recent years.

She has more than 300 scientific publications (H-index 64) and several published books and book chapters. Professor Vilsbøll is a frequently invited speaker at national and international meetings. Professor Vilsbøll is an experienced teacher and supervises several PhD and medical students conducting diabetes research.

In addition to her teaching and research posts, Professor Vilsbøll is a member of numerous professional societies and committees, and referees for several international journals. 

Duality of Interest: Professor Vilsbøll has received research support grants from Eli Lilly and Novo Nordisk and board member/ advisory panel fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sun Pharmaceuticals. She has also received consultancy payments from Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Mundipharma, Novo Nordisk, Sanofi and Sun Pharmaceuticals.
Date: Summer 2023